Results for prior to launch translation from English to Maltese

no url to launch
l-ebda indirizz elettroniku (url) li għandu jinfetaħ ma ġie mogħti

scan this code to launch
skannja dan il-kodiĊi biex tibda

bad command (exec) to launch
kmand ħażin (exec) biex jitħaddem

commission to launch bioeconomy observatory
il-kummissjoni se tniedi osservatorju bijoeconomiku

does the commission want to launch new legislation?
il-kummissjoni tixtieq tniedi leġiżlazzjoni ġdida?

the mah should agree the educational material with the member states, prior to launch.
l-mah (marketing authorization holder – detentur tal-awtorizzazzjoni għat-tqegħid fis-suq) għandu jiftiehem dwar il-materjal edukattiv mal-istati membri, qabel it-tnedija.

prior to launch, the mah shall agree on the implementation of a patient card system in each member sate.
qabel ma jintroduċih, il- mah għandu jiftiehem fuq l- implimentazzjoni ta ’ sistema ta ’ kard għall- pazjent f’ kull stat membru.

prior to launch, the mah shall agree on the implementation of a patient card system in each member state.
qabel ma jintroduċih, il- mah għandu jiftiehem fuq l- implimentazzjoni ta ’ sistema ta ’ kard għall- pazjent f’ kull stat membru.

the educational pack must be available for distribution for all therapeutic indications prior to launch ) in the member state.
il- pakkett edukattiv irid ikun disponibbli għad-distribuzzjoni kemm għal indikazzjonijiet terapewtiċi kollha qabel it-tnedija fl-istat membru.

prior to launch in each member state the mah shall agree the final educational material with the national competent authority.
qabel it-tnedija f’kull stat membru l-mah għandu jaqbel dwar il-materjal edukattiv aħħari mal- awtorità kompetenti nazzjonali.

the mah shall provide an educational pack prior to launch, targeting all physicians who are expected to prescribe/use eliquis.
l-mah għandu jipprovdi pakkett edukattiv qabel it-tnedija tal-prodott fis-suq, lit-tobba kollha li mistennija jagħmlu riċetta/ jużaw eliquis.

prior to launch of deferasirox film-coated tablets, healthcare professionals will receive introductory notification letters as follows:
qabel it-tnedija ta’ deferasirox pilloli miksija b’rita, professjonisti fil-qasam tal-kura tas-saħħa se jirċievu ittri b’informazzjoni introduttorja kif ġej:

the member states shall agree with the marketing authorisation holder, prior to launch, measures for the implementation of the following:
l- istati membri għandhom jaqblu mad- detentur ta ’ l- awtorizzazzjoni għat- tqegħid fis- suq, qabel it - tnedija, fuq miżuri għall- implimentazzjoni ta ’ dawn li ġejjin: − kors ta ’ taħriġ għal newrokirurgi li huwa mmirat għall- minimizzazzjoni tar- riskji u biex jiġi appoġġjat l- użu sikur u effettiv għall- prodott.

prior to launch in each member state, the mah shall agree the final educational material with the competent authority in that member state.
qabel it-tnedija f’kull stat membru, il-mah għandu jaqbel fuq il-materjal edukattiv finali mal- awtorità kompetenti f’dak l-istat membru.

prior to launch in member states, the mah shall establish a disease registry to gather long term safety data and outcome endpoints in patients with epp.
qabel it-tnedija fl-istati membri, l-mah għandu jistabbilixxi reġistru tal-marda sabiex jiġbor dejta tas-sigurtà fuq perjodu ta’ żmien twil u punti finali tal-effett fil-pazjenti b’epp.

prior to launch in each member state the marketing authorisation holder (mah) shall agree the following with the national competent authority:
qabel it-tnedija f’kull stat membru d-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq (mah) għandu jaqbel ma’ dan li ġej mal-awtorità nazzjonali kompetenti:

prior to launch, all doctors who intend to prescribe revlimid and all pharmacists who may dispense revlimid receive a direct healthcare professional communication as described below.
qabel il-lanċjar, it-tobba kollha li jkollhom l-intenzjoni li jagħtu riċetta għal revlimid, u l- ispiżjara kollha li jistgħu jagħtu revlimid, jirċievu komunikazzjoni diretta tal-professjonisti fil-qasam tas-saħħa kif deskritt hawn taħt.

the results of the discussion, and where appropriate the material, should be agreed with the national competent authority and be available prior to launch in each member state.
ir-riżultati tad-diskussjoni, kif ukoll jekk ikun hemm bżonn il-materjal, għandhom jiġu miftiehma mal-awtorità kompetenti nazzjonali u jkunu disponibbli qabel il-ħruġ tal-prodott fis-suq f’kull stat membru.

b) prior to launch in any eu member state, the mah will set up an immunosurveillance programme and provide antibody testing for anti-atryn antibodies to physicians.
b) qabel it- tnedija fi kwalunkwe stat membru ta 'l- ue, il- mah ser iwaqqaf programm ta' immunosorveljanza u jipprovdi ittestjar ghall- anti- korpi ta 'l- anti- atryn lit- tobba.

prior to launch, the mah shall ensure that the educational programme implemented for currently authorised indications is extended to the potential prescribers concerned by the new indication, juvenile idiopathic arthritis.
qabel ma l- prodott mediċinali jinħareġ fis- suq, id- detentur ta ’ l- awtorizzazzjoni għat- tqegħid fis- suq għandu jaċċerta ruħu li l- programm edukattiv implimentat għall- prodott mediċinali bil - qawwiet li huma awtorizzati bħalissa jiġi estiż għal dawk it- tobba li għad jippreskrivu l- prodott mediċinali bl- indikazzjoni l- ġdida tiegħu, l- artrite idjopatika taż- żagħżagħ.